Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
मुख्य लेखकों: | Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR |
---|---|
स्वरूप: | Conference item |
प्रकाशित: |
2011
|
समान संसाधन
-
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
द्वारा: Gillies, R, और अन्य
प्रकाशित: (2012) -
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
द्वारा: Gillies, R, और अन्य
प्रकाशित: (2012) -
XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
द्वारा: Hatch, S, और अन्य
प्रकाशित: (2014) -
Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
द्वारा: Graf, Nora, और अन्य
प्रकाशित: (2012) -
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
द्वारा: MacGregor, T, और अन्य
प्रकाशित: (2018)